TERT Promoter Mutations in Papillary Thyroid Microcarcinomas
Thyroid2015Vol. 25(9), pp. 1013–1019
Citations Over TimeTop 10% of 2015 papers
Dario de Biase, Greta Gandolfi, Moira Ragazzi, Markus Eszlinger, Valentina Sancisi, Mila Gugnoni, Michela Visani, Annalisa Pession, Gianpaolo Casadei, Cosimo Durante, Giuseppe Costante, Rocco Bruno, Massimo Torlontano, Ralf Paschke, Sébastiano Filetti, Simonetta Piana, Andrea Frasoldati, Giovanni Tallini, Alessia Ciarrocchi
Abstract
TERT mutations are present but uncommon in mPTCs. Apparently, in mPTCs, the occurrence of TERT mutations is not correlated with unfavorable clinical features.
Related Papers
- → Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013(2017)2,150 cited
- → Lessons from Mouse Models of Thyroid Cancer(2009)52 cited
- → CDK12 promotes papillary thyroid cancer progression through regulating the c-myc/β-catenin pathway(2020)20 cited
- → Modern aspects influencing the management of patients with papillary thyroid cancer(2023)3 cited
- → Evaluation of the Relationship Between Papillary Thyroid Cancer and Radiation Exposure(2024)